Skip to content

Serial Hybrid Atrial Fibrillation Ablation

Serial Hybrid Atrial Fibrillation Ablation

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01582828
Acronym
SHAFT
Enrollment
0
Registered
2012-04-23
Start date
2012-08-31
Completion date
2017-12-31
Last updated
2024-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

atrial, fibrillation, pvi, vats, ablation, hybrid

Brief summary

Treatment of (long-standing) persistent atrial fibrillation (AF) remains cumbersome and the surgical (epicardial) approach seems to be the most effective. Still, however a significant amount of failures exist which is mostly due to incompleteness of the surgical ablation lines. Checking, and if necessary additional ablation, of these lines afterwards endocardially by the cardiologist (the so-called serial hybrid approach) could overcome this problem.

Interventions

PROCEDUREEpicardial (surgical) ablation

* Pulmonary vein isolation with bipolar clamps and bipolar box lesion * Epicardial atrial appendage closure

PROCEDUREHybrid

Epicardial (surgical) ablation * Pulmonary vein isolation with bipolar clamps and bipolar box lesion * Epicardial atrial appendage closure Endocardial assessment after 6-8 weeks, checking for isolation and if necessary touch up by RF ablation

Sponsors

Medisch Spectrum Twente
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients are screened and accepted for pulmonary vein isolation according to the current guidelines * long standing persistent or persistent AF as defined in the guidelines * left atrial size needs to be more than \>46 mm on long axis or \>35 cc/m2 * CHADSVASC score should be more than 0 as an indicator of a substantial substrate for atrial fibrillation.

Exclusion criteria

* Significant coronary artery disease has to be excluded as a trigger for AF by means of cardiac CT, if necessary a coronary angiogram will be performed. * Previous PVI ablation (epicardial or endocardial) or cardiac surgery. * Significant valvular disease present on echo. * Concomitant cardiac surgery needed.

Design outcomes

Primary

MeasureTime frameDescription
Atrial fibrillation Freedom12 monthsleft sided atrial flutter and left atrial tachycardia

Secondary

MeasureTime frameDescription
re-isolation8-10 weeksnumber of pulmonary veins needing re-isolation by the EP
Percentage of cross-over1 yearPercentage of cross-over from the surgical arm alone to surgery and serial hybrid ablation.
Complications1 yearNumber of complications and thrombo-embolic events in both groups
Atrial fibrillation Burden1 yearBurden of AF in both groups if AF is still present.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026